Skip to main content

Table 1 Clinicopathologic characteristics of all 26 patients

From: Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer

Characteristics

No of patient

%

Age, median = 63.4 (36.4-74.1)

  

   30- 60

10

38.5%

   > 60

16

61.5%

Sex (n = 26)

  

   Male

22

84.6%

   Female

4

12.5%

Stage at diagnosis (n = 26)

  

   Stage IB

3

11.5%

   Stage II

6

23.1%

   Stage III

7

26.9%

   Stage IV

10

38.5%

Endoscopic finding (n = 23)

  

   Borrmann type I

2

8.7%

   Borrmann type II

5

21.7%

   Borrmann type III

11

47.8%

   Borrmann type IV

1

4.3%

   EGC†

4

17.4%

Location (n = 25)

  

   Upper-third

2

8.0%

   Middle-third

5

20.0%

   Lower-third

16

64.0%

   Whole stomach

2

8.0%

Immunohitstochemical staining (n = 26)

  

   AFP (positive/negative/‡NA)

15/4/7

 

   Anti-hepatocyte (positive/negative/‡NA)

4/4/18

 

   Anti-chymotrypsin (positive/negative/‡NA)

1/1/24

 

Serum AFP (n = 26)

  

   Elevated (median, range)

7 ( 208 ng/ml,

5-4,750,000 ng/ml)

 

   Normal

4

 

   ‡NA

15

 
  1. † Early gastric cancer type, ‡Not assessed